Skip to main content
. 2016 Feb 24;7(13):16479–16489. doi: 10.18632/oncotarget.7660

Table 1. Sequences of primers used in this study.

Name Sequences (5′→3′) Product size (bp)
Nanog Forward CCT GAT TCT TCT ACC AGT CCC A 123
Nanog Reverse GGC CTG AGA GAA CAC AGT CC
Sox2 Forward GCA CAT GAA CGG CTG GAG CAA CG 207
Sox2 Reverse TGC TGC GAG TAG GAC ATG CTG TAG G
Oct4 Forward ATG TTT CTG AAG TGC CCG AA 85
Oct4 Reverse AGA GAA GGA TGT GGT TCG AG
cMyc Forward TGA CCT AAC TCG AGG AGG AGC TGG AAT C 170
cMyc Reverse AAG TTT GAG GCA GTT AAA ATT ATG GCT GAA GC
β-Actin 184 Forward AGA GCT ACG AGC TGC CTG AC 184
β-Actin 184 Reverse AGC ACT GTG TTG GCG TAC AG